LGRCX | RGEBX | LGRCX / RGEBX | |
Total Expense Ratio | 1.66 | 1.09 | 152% |
Annual Report Gross Expense Ratio | 1.67 | 1.09 | 153% |
Fund Existence | 22 years | 11 years | - |
Gain YTD | 8.901 | 12.808 | 69% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 250 | 1,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 17.5B | 330B | 5% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 13.59 | 11.57 | 117% |
Returns for 3 years | 38.10 | 42.94 | 89% |
Returns for 5 years | 26.77 | 36.74 | 73% |
Returns for 10 years | 150.43 | 89.38 | 168% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
EWQ | 43.82 | 0.27 | +0.62% |
iShares MSCI France ETF | |||
INTF | 35.49 | -0.01 | -0.03% |
iShares International Equity Factor ETF | |||
ZDEK | 24.88 | -0.05 | -0.21% |
Innovator Equity Defined Prt ETF -1YrDec | |||
EPHE | 26.25 | -0.09 | -0.34% |
iShares MSCI Philippines ETF | |||
BBC | 22.08 | -0.70 | -3.09% |
Virtus LifeSci Biotech Clinical Trls ETF |